Fig. 5
From: REmoval of cytokines during CArdiac surgery (RECCAS): a randomised controlled trial
Clinical outcomes after HA. Bar graphs depicting Cardiac Index (CI) (A), duration of dobutamine need in hours until d2 (control: n = 6, treatment group n = 10) (B), duration of adrenaline need in hours until d3 (control: n = 2, treatment group n = 2) (C), need for crystalloid fluid replacement up to d1 (D), duration of renal-replacement-therapy (RRT) (control: n = 3, treatment group n = 3) (E), number of patients needing fibrinogen (black) (F) during the course of intensive care unit (ICU) treatment (admission, day 1 (d1), and day 2 (d2) at ICU) comparing controls (white bars, n = 19) and treatment group (dark grey bars) having received haemoadsorption (HA) during cardiothoracic surgery with cardiopulmonary bypass (CPB). All variables are presented as mean ± standard deviation (SD), except panel F presenting number of patients and percentage. N = 39. Statistical analysis: A–C t-test, D chi-square